Acasti Pharma Inc.
ACST
Rangering i aksjer
#29734
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Aksjekurs
$0.4256834
Sist synkronisert: 2023-03-27
Markedsverdi
$18.99M
Endring (1 dag)
3.08%
Endring (1 år)
-87.02%
Land
CA
Handel Acasti Pharma Inc. (ACST)
Kategori
Healthcare
EPS for Acasti Pharma Inc. (ACST)
EPS per June 2026 TTM: $-1.17
Ifølge de siste økonomiske rapportene og aksjekursen til Acasti Pharma Inc. er selskapets nåværende EPS (TTM) $-1.17. Ved slutten av 2024 hadde selskapet en EPS på $-1.35, en nedgang sammenlignet med EPS-en i 2023 som var $-5.71.
EPS-historikk for Acasti Pharma Inc. fra 2010 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $-1.17 | 48.10% |
| 2025 | $-0.79 | -41.48% |
| 2024 | $-1.35 | -76.36% |
| 2023 | $-5.71 | 256.88% |
| 2022 | $-1.60 | -79.90% |
| 2021 | $-7.96 | -5.01% |
| 2020 | $-8.38 | 73.17% |
| 2019 | $-4.84 | -19.49% |
| 2018 | $-6.01 | -61.25% |
| 2016 | $-15.51 | 224.41% |
| 2015 | $-4.78 | -91.08% |
| 2014 | $-53.58 | 24.03% |
| 2013 | $-43.20 | -8.51% |
| 2012 | $-47.22 | 102.66% |
| 2011 | $-23.30 | -26.64% |
| 2010 | $-31.76 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $17.32 | -1,580.34% |
US
|
|
| $-7.98 | 582.05% |
US
|
|
| $-5.29 | 352.14% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,470.94% |
NL
|
